Enterprise Value

566.4M

Cash

157.5M

Avg Qtr Burn

-13.99M

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

94.00%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
ARX788 Details
Solid tumor/s, Cancer, Breast cancer, Gastric cancer, Gastroesophageal junction tumors

Big Mover™

Susp. Mover™

Phase 2/3

Data readout

ARX517 Details
Solid tumor/s, Cancer, Prostate cancer

Phase 1

Data readout